Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D F Sahm

Showing results (31-40 of 89) with videos related to

Pageof 9
Sort By:
Antimicrobial Agents and Chemotherapy|April 1, 1997
Heterogeneous expression of glycopeptide resistance in enterococci associated with transfer of vanBM K Hayden, R N Picken, D F Sahm
Antimicrobial Agents and Chemotherapy|June 19, 2013
In vitro activity of CEM-102 (fusidic acid) against prevalent clones and resistant phenotypes of Staphylococcus aureusD F Sahm, J Deane, C M Pillar, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 5, 2001
Antimicrobial resistance among uropathogens that cause community-acquired urinary tract infections in women: a nationwide analysisK Gupta, D F Sahm, D Mayfield, et al.
Archives of Dermatological Research|January 1, 1986
Organisms associated with gram-negative folliculitis: in vitro growth in the presence of isotretinoinS Simjee, D F Sahm, K Soltani, et al.
Antimicrobial Agents and Chemotherapy|October 30, 1999
Survey of susceptibilities of Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis isolates to 26 antimicrobial agents: a prospective U.S. studyC Thornsberry, P T Ogilvie, H P Holley, et al.
Journal of Clinical Microbiology|September 1, 1984
Influence of growth medium on the in vitro activities of second- and third-generation cephalosporins against Streptococcus faecalisD F Sahm, C N Baker, R N Jones, et al.
Antimicrobial Agents and Chemotherapy|September 3, 1999
VanE, a new type of acquired glycopeptide resistance in Enterococcus faecalis BM4405M Fines, B Perichon, P Reynolds, et al.
The Journal of Antimicrobial Chemotherapy|May 1, 1999
Prevalence of Acinetobacter spp. isolates with reduced susceptibility to imipenem, as determined by a USA-wide electronic surveillance networkM E Jones, C Thornsberry, D M Livermore, et al.
Antimicrobial Agents and Chemotherapy|August 22, 2000
Analysis of ciprofloxacin activity against Streptococcus pneumoniae after 10 years of use in the United StatesD F Sahm, D E Peterson, I A Critchley, et al.
Journal of Clinical Microbiology|October 1, 1983
Medium-dependent zone size discrepancies associated with susceptibility testing of group D streptococci against various cephalosporinsD F Sahm, C N Baker, R N Jones, et al.
Pageof 9

Showing results (31-40 of 89) with videos related to

Sort By:
Pageof 9
Antimicrobial Agents and Chemotherapy|April 1, 1997
Heterogeneous expression of glycopeptide resistance in enterococci associated with transfer of vanBM K Hayden, R N Picken, D F Sahm
Antimicrobial Agents and Chemotherapy|June 19, 2013
In vitro activity of CEM-102 (fusidic acid) against prevalent clones and resistant phenotypes of Staphylococcus aureusD F Sahm, J Deane, C M Pillar, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 5, 2001
Antimicrobial resistance among uropathogens that cause community-acquired urinary tract infections in women: a nationwide analysisK Gupta, D F Sahm, D Mayfield, et al.
Archives of Dermatological Research|January 1, 1986
Organisms associated with gram-negative folliculitis: in vitro growth in the presence of isotretinoinS Simjee, D F Sahm, K Soltani, et al.
Antimicrobial Agents and Chemotherapy|October 30, 1999
Survey of susceptibilities of Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis isolates to 26 antimicrobial agents: a prospective U.S. studyC Thornsberry, P T Ogilvie, H P Holley, et al.
Journal of Clinical Microbiology|September 1, 1984
Influence of growth medium on the in vitro activities of second- and third-generation cephalosporins against Streptococcus faecalisD F Sahm, C N Baker, R N Jones, et al.
Antimicrobial Agents and Chemotherapy|September 3, 1999
VanE, a new type of acquired glycopeptide resistance in Enterococcus faecalis BM4405M Fines, B Perichon, P Reynolds, et al.
The Journal of Antimicrobial Chemotherapy|May 1, 1999
Prevalence of Acinetobacter spp. isolates with reduced susceptibility to imipenem, as determined by a USA-wide electronic surveillance networkM E Jones, C Thornsberry, D M Livermore, et al.
Antimicrobial Agents and Chemotherapy|August 22, 2000
Analysis of ciprofloxacin activity against Streptococcus pneumoniae after 10 years of use in the United StatesD F Sahm, D E Peterson, I A Critchley, et al.
Journal of Clinical Microbiology|October 1, 1983
Medium-dependent zone size discrepancies associated with susceptibility testing of group D streptococci against various cephalosporinsD F Sahm, C N Baker, R N Jones, et al.
Pageof 9